SPDR S&P Biotech ETF
196 hedge funds and large institutions have $3.25B invested in SPDR S&P Biotech ETF in 2015 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 149 increasing their positions, 9 reducing their positions, and 33 closing their positions.
Holders
196
Holders Change
+3
Holders Change %
+1.55%
% of All Funds
5.48%
Holding in Top 10
6
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-45.45%
% of All Funds
0.17%
New
38
Increased
149
Reduced
9
Closed
33
Calls
$525M
Puts
$1.34B
Net Calls
-$819M
Net Calls Change
+$557M
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$925M |
| 2 |
2
Morgan Stanley
New York
|
$746M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$222M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$244M |
| 5 |
5
Citigroup
New York
|
$177M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TPCM
251
Tide Point Capital Management
Old Greenwich,
Connecticut
| – | – | – | – |
|
|
PAMP
252
Polar Asset Management Partners
Toronto,
Ontario, Canada
| – | – | – | – |
|
|
SC
253
Sculptor Capital
New York
| – | – | – | – |
|
|
MIG
254
Mariner Investment Group
Harrison,
New York
| – | – | – | – |
|
|
ST
255
Spot Trading
Chicago,
Illinois
| – | – | – | – |
|
|
UOC
256
UBS O'Connor
Chicago,
Illinois
| – | – | – | – |
|
|
ST
257
Sphinx Trading
Chicago,
Illinois
| – | – | – | – |
|
|
TM
258
Thiel Macro
Los Angeles,
California
| – | – | – | – |
|
|
LCM
259
Laurion Capital Management
New York
| – | – | – | – |
|
|
ACG
260
Anchorage Capital Group
New York
| – | – | – | – |
|
|
FANJ
261
Financial Architects (New Jersey)
Marlton,
New Jersey
| – | – | – | – |
|
|
PA
262
Perceptive Advisors
New York
| – | – | – | – |
|
263
Parallax Volatility Advisers
San Francisco,
California
| $0 | 3 | +2 | +200% |
|